About
Trusted Partner in Korean Diagnostics
CEO Message
Since its foundation on January 11, 2000
DK Holdings has built a strong reputation in the Korean diagnostics market through long-standing industry experience, trusted partnerships, and consistent execution.
Originally established under the name DIATECH Korea, our philosophy has always been centered on one belief
Driving Innovation Across Trusted Ecosystems in Commercial Healthcare
We believe innovation becomes truly meaningful when it creates real value within healthcare systems and reaches the people who need it most.
This philosophy is reflected in what we call Diagnostic Kraft — the expertise, commitment, and execution capability that transform innovative diagnostic technologies into meaningful healthcare solutions.
Today, DK Holdings serves as a trusted commercialization partner for global diagnostic innovators, connecting advanced diagnostic technologies with the Korean healthcare ecosystem through strategic execution, market expertise, and long-term partnerships.
As the diagnostics industry continues to evolve, we remain committed to building trusted ecosystems that advance diagnostics in Korea.
President & CEO
Joon Sang Park
Leadership
Joon Sang Park
President & CEO
Joon Sang Park earned his bachelor's degree in political science from the University of Massachusetts Amherst and later completed his master's degree at Yonsei University (Global MBA).
Prior to leading DK Holdings and APRILIS, he gained experience in the global healthcare and life sciences industry through roles at Charles River Laboratories and Roche Pharmaceuticals.
Since joining DK Holdings, he has focused on building trusted partnerships and advancing strategic commercialization in Korean diagnostics by connecting global diagnostic innovation with the Korean healthcare ecosystem.
